>>
Home > Programs & Groups > Core Technologies > Translational Genomics Group

PROGRAMS & GROUPS

Aleix Prat
Principal Investigator:
ALEIX PRAT

CORE TECHNOLOGIES

Translational Genomics Group

  1.  Help implement and develop clinically applicable genomic platforms and tests
  2. Participate in retrospective correlative science studies using tumor samples from clinical trials
  3. Validate predictive and/or prognostic genomic-based biomarkers in prospective clinical trials
  4. Evaluate gene expression data as a tool to identify drug sensitivity/resistance mechanisms
  5. Help investigators perform and analyze genomic data

VHIO NEWS ARTICLES:

13/02/2013: Gene expression refines triple-negative breast cancer diagnosis

20/12/2012: Gene expression improves the definition of a breast cancer subtype

19/11/2012:  Aleix Prat awarded third International Prize for Breast Cancer Research          for bringing gene expression technology closer to the clinic

IN THE MEDIA (links to selected coverage):

22/04/2013 DIARIO MEDICO: Plataformas genómicas: una herramienta con protagonismo creciente

20/12/2012 LA VANGUARDIA: Vall d'Hebron mejora el diagnóstico del cáncer de mama

20/12/2012 ABC: Hallan un nuevo marcador el diagnóstico de los cánceres de mama

20/12/2012 TVE Catalunya (min 11´, 15"): L'expressió gènica millora la definició d'un subtipus de càncer de mama